Is prosthetic valve thrombogenicity related to design or material?

Texas Heart Institute Journal

Volumn 23, Issue 1, 1996, Pages 24-27

  Edmunds Jr , L Henry ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biocompatible materials; heart valve prosthesis; history of medicine, 20th cent.; thromboembolism

Indexed keywords

BIOCOMPATIBILITY; CONFERENCE PAPER; HEART VALVE PROSTHESIS; HUMAN; PATHOGENESIS; THROMBOGENICITY; THROMBOSIS; VALVULAR HEART DISEASE;

ANTICOAGULANTS; BIOCOMPATIBLE MATERIALS; ENDOTHELIUM, VASCULAR; HEART VALVE PROSTHESIS; HISTORY, 20TH CENTURY; HUMANS; PROSTHESIS DESIGN; THROMBOEMBOLISM;

EID: 0029968156     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Hufnagel CA, Harvey WP The surgical correction of aortic regurgitation; preliminary report. Bull Georgetown Univ Med Center 1953,6-3.
2. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery Minn Med 1954;37:171-80.
3. Merendino KA, editor. Prosthetic valves for cardiac surgery. Springfield (IL): Charles C Thomas, 1961.
4. Starr A, Edwards ML. Mitral replacement, clinical experience with a ball-valve prosthesis. Ann Surg 1961;154.726-40
5. Macmanus Q, Grunkemeier G, Thomas D, Lambert LE, Starr A The Starr-Edwards model 6000 valve. A fifteen-year follow-up of the first successful mitral prosthesis Circulation 1977;36(4 Pt 1):623-5.
6. Dutton RC, Webber AJ, Johnson SA, Baier RE Microstructure of initial thrombus formation on foreign materials. J Biomed Mater Res 1969;3:13-23.
7. Ziats NP, Pankowsky DA, Tierney BP, Ratnoff OD, Anderson JM Adsorption of Hageman factor (factor XII) and other human plasma proteins to biomedical polymers J Lab Clin Med 1990;116:687-96.
8. Schoen FJ, Libby P, Didisheim P Future directions and therapeutic approaches. Cardiovasc Pathol 1993,2(3 Suppl) 209S-216S.
9. Gluszko P, Rucinski B, Musial J, Wenger RK, Schmaier AH, Colman RW, et al. Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit Am J Physiol 1987;252(3 Pt 2):H615-21
10. Pumphrey CW, Dawes J. Platelet alpha granule depletion findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery. Thromb Res 1983;30: 257-64.
11. Harker LA, Slichter SJ. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves N Engl J Med 1970;283 1302-5.
12. Colman RW. Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest 1984;73 1249-53.
13. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH-report - Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis Thromb Haemost 1986;55:415-35
14. Slack SM, Turitto VT. Fluid dynamic and hemorheologic considerations Cardiovasc Pathol 1993;2(3 Suppl):11S-21S
15. Helmus MN, Hubbell JA. Materials selection Cardiovasc Pathol 1993;2(3 Suppl).53S-71S
16. Edmunds LH Jr Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987;44 430-45.
17. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, Breckenridge IM. Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation. Experience with 1,004 Medtronic Hall valves Circulation 1988;78(3 Pt 2):I-66-77
18. FitzGerald GA Dipyridamole N Engl J Med 1987;316:1247-57.
19. Patrono C, Ciabattoni G, Pinca E. Pugliese F, Castrucci G, De Salvo A, et al. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 1980; 17 317-27.
20. Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 1993;329:524-9.